Mid-Tier IT Firms Outpace TCS, Infosys in FY25 Growth
India's mid-cap IT firms are showing remarkable growth momentum, outperforming industry giants TCS and Infosys in revenue expansion and market performance as FY25 unfolds.
India's mid-cap IT firms are showing remarkable growth momentum, outperforming industry giants TCS and Infosys in revenue expansion and market performance as FY25 unfolds.
India's wealthiest philanthropists including Shiv Nadar, Mukesh Ambani, Bajaj, Birla, Adani, Nilekani and Hinduja families have collectively donated over ₹100 crore in FY25, driving transformative change across education, healthcare and social development
Apollo Hospitals delivers stellar Q2 FY25 performance with robust profit growth and strong revenue expansion, showcasing healthcare sector resilience.
Brigade Enterprises sets November 6, 2024 for Q2 FY25 results and potential second interim dividend declaration. Discover why Quant Mutual Fund's significant stake makes this real estate stock one to watch.
Sigma Solve Limited reports impressive Q2 FY25 results with 54% YoY profit surge, revenue growth of 26.65%, and expanding EBITDA margins. The tech solutions provider demonstrates strong financial performance.
India's coffee industry is experiencing unprecedented growth with exports skyrocketing 40% to reach $1.8 billion in FY25, marking the fourth consecutive year of impressive expansion. Discover how Indian coffee is conquering global markets.
Indian coffee exports continue their impressive growth streak for the fourth consecutive year, reaching USD 1.8 billion in FY25, driven by robust European demand and premium quality beans.
Indian edtech major UpGrad reports strong EBITDA profitability in FY25's first quarter, driven by AI-powered learning solutions and strategic international growth across 50+ countries.
Vaibhav Global Limited (VGL) delivers outstanding Q2 FY25 results with 71% YoY PAT surge to ₹48 crore and 11% revenue growth. Discover how this retail giant is dominating the electronic retail space.
India's merchandise exports to the United States show remarkable resilience with 3% growth in first half of FY25, even as monthly figures show temporary declines. SBI Research reveals surprising trade dynamics.
Dr. Reddy's Laboratories delivers stellar Q2 FY25 results, beating revenue and profit forecasts. Discover how their pharmaceutical business and nicotine replacement portfolio drove exceptional performance.
Interior design platform HomeLane marks major milestone with 22% revenue surge to ₹735 crore in FY25 and achieves EBITDA profitability in Q4, signaling strong market recovery and operational efficiency.
Bangalore-based fintech pioneer Innoviti Technologies reports impressive 35% revenue surge in FY25, driven by robust payment solutions adoption across retail and enterprise sectors.
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
Corporate India's Q2 performance falls short of expectations, but analysts remain bullish on second-half FY25 recovery. Discover what's driving the optimism despite current challenges.
India's automobile export sector shows robust growth with 26.3% increase in Q2 FY25. Passenger vehicles and two-wheelers lead the charge, signaling strong global demand for Indian-made vehicles.
India's automobile export sector shows robust growth with 26% increase in Q2 FY25. Discover how passenger vehicles and two-wheelers are driving this impressive expansion in global markets.
HDFC Bank reports impressive Q2 FY25 results with 10.8% net profit growth reaching ₹18,640 crore. Discover how India's leading private bank achieved robust performance despite economic headwinds.
HDFC Bank reports robust Q2 FY25 performance with 11% profit growth, 5% rise in net interest income, and significant improvement in asset quality metrics. Key highlights and analysis.